Partnerships to be proud of.
We have forged strategic partnerships with leading companies around the world. Our operating model allows us to leverage our strengths globally, while enjoying local market expertise, whether it is a US state’s medical marijuana program or one of many regulated international markets. We can act with unmatched speed and agility in reaction to evolving market conditions to reach our goal of improving the lives of as many people around the world as we can.
Ultra Health is New Mexico’s top medical cannabis grower with over 30% of local market share.
The company aims to provide New Mexico residents with easier access to the cutting-edge products for therapeutic needs. Ultra Health carries a variety of medical cannabis strains and products including concentrates, topicals, edibles, THC and CBD products, as well as delivery systems. Panaxia and Ultra Health announced their partnership in March 2016 and within a year launched their first pharmaceutical cannabis production facility in Bernalillo, New Mexico.
MPX Bioceutical Corporation (formerly BCC) aims to become one of the largest players in the adult cannabis industry. MPX Bioceutical Corporation owns subsidiaries in the United States, and provides management, staff, advisory, financial, procurement and administrative services to two ventures in Arizona. MPX Bioceutical Corporation provides the support necessary for its partners to successfully market their therapeutic cannabis partners. Panaxia and MPX Bioceutical Corporation announced their partnership in Summer 2017. Under the agreement, Panaxia will provide smokeless, pharma-grade products that are not easily obtainable in the United States.
Salus Biopharma’s mission is to provide medical cannabis products developed with cutting edge technologies to the highest available pharmacy standards. The Company manufactures and markets pharmacy grade cannabis based products developed with partner Panaxia Industries Inc. All products are manufactured to GMP standards and provide accurate, specific and reproducible dosing. Salus Biopharma is a wholly-owned subsidiary of MPX Bioceutical Corporation.
BGM a privately owned Biotechnology company in the Republic of South Africa located in the City of Johannesburg, the technological hub and business innovation centre of South Africa.
BGM recognises the need for the development of new therapies as well as improvement of existing therapies. BGM is committed to investing significantly into various research programmes that will empower future generation.
Pharmocann is one of the pioneering companies in Israel’s vast pharmaceutical cannabis industry.
Pharmocann’s farm was established nearly a decade ago in the Jezreel Valley in Israel’s north and sits on 8 acres of land.
The company produces ten strains of medical cannabis and has the capacity to produce two tons of product a year, reaching 3,000 patients.
TevaAdir is a medical cannabis supplier with farms located in Israel’s sunny southern region, near the city of Eilat and the Red Sea.
The company’s crops are grown with all-natural ingredients to deliver the highest quality product. TevaAdir offers both pure and hybrid strains to cater to a variety of solutions.
Better has over 15 years of experience and knowledge in production of cannabis strains for medical usage. Specializing in organic growing techniques and developing unique products for different delivery system, Better has become one of the first and largest producers of Medical Grade Cannabis in Israel and is expanding to the global market to create a Better world.